Market Overview

Benzinga's Top Downgrades

Share:
Related FINL
Mid-Day Market Update: Finish Line Drops On Weak Results; Dynavax Shares Spike Higher
Finish Line's Big Q3 Earnings Miss And Concerning Guidance Has Shares Down 16%
Related ELN
Perrigo, Elan Receive Irish High Court Approval for Perrigo's Proposed Acquisition of Elan
Perrigo Shareholders Approve Acquisition Of Elan

Sterne Agee downgraded Finish Line Inc (NASDAQ: FINL) from “buy” to “neutral.” FINL's shares closed at $21.13 yesterday. Finish Line's trailing-twelve-month operating margin is 9.97%.

Analysts at UBS downgraded Elan Corporation plc (NYSE: ELN) from “buy” to “neutral.” ELN's shares closed at $14.50 yesterday. Elan's PEG ratio is -19.57.

RW Baird downgraded Amylin Pharmaceuticals Inc (NASDAQ: AMLN) from “outperform” to “neutral.” AMLN's shares closed at $27.44 yesterday. Amylin Pharmaceuticals' trailing-twelve-month ROE is -348.55%.

William Blair downgraded Booz Allen Hamilton Inc (NYSE: BAH) from “outperform” to “market perform.” BAH's shares closed at $16.86 yesterday. Booz Allen Hamilton's trailing-twelve-month profit margin is 3.57%.

Latest Ratings for FINL

DateFirmActionFromTo
Feb 2016Credit SuisseAssumesNeutral
Jan 2016Credit SuisseMaintainsNeutral
Jan 2016B. RileyMaintainsBuy

View More Analyst Ratings for FINL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AMLN + BAH)

Get Benzinga's Newsletters